European Journal of Haematology (EJH)

The European Journal of Haematology is a leading peer‑reviewed scientific journal dedicated to advancing hematology research globally. Established in 1987, the journal is published monthly by John Wiley & Sons Ltd (Wiley‑Blackwell) and has an extensive record of disseminating high‑quality original research, clinical investigations, and comprehensive reviews in the field of blood science. The scope includes fundamental molecular and cellular studies of hematopoiesis, coagulation, thrombosis, and related physiological processes, as well as clinical research addressing blood disorders such as leukemias, lymphomas, anemias, and hemoglobinopathies. The journal provides a platform for studies that bridge laboratory findings with clinical practice, encompassing both experimental insights and patient‑oriented outcomes. Under the editorial leadership of Prof. Karl‑Anton Kreuzer, European Journal of Haematology ensures rigorous peer review and scientific integrity, helping to shape contemporary hematology knowledge and evidence‑based practice in medicine. Indexed in major databases including MEDLINE, Web of Science, and Scopus, the journal attracts contributions from basic scientists, clinical researchers, and healthcare professionals worldwide. Its consistent publication history and broad subject coverage make it an important resource for researchers, clinicians, educators, and policymakers involved in the study and treatment of blood diseases.

European Journal of Haematology (EJH) is :-

• International, Peer-Reviewed, Open Access, Refereed, Hematology, General Medicine, molecular, cellular, and clinical research related to blood diseases, blood cell development, vascular and lymphatic tissue disorders, haemostasis , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0902-4441, E-ISSN: 1600-0609, Established: 1987, Impact Factor: 2.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE